Pharmaceutical

Change in Generic Drug Prices Linked to Market Competition

Change in Generic Drug Prices Linked to Market Competition

The study noted a price change of -31.7% for quadropoly and 47.4% for monopoly.

FDA Aims to Increase Number of Generic Drugs on the Market

FDA Aims to Increase Number of Generic Drugs on the Market

The agency will now give priority reviews to new generic drugs until there are at least 3 available.

Former Pharma Representatives Being Used by Health Insurers to Lower Costs

Former Pharma Representatives Being Used by Health Insurers to Lower Costs

Former pharma reps are educating doctors about costs of medications and encouraging the use of generic drugs.

Dermatologists Shown to Receive Significant Industry Payments from Pharmaceuticals

Dermatologists Shown to Receive Significant Industry Payments from Pharmaceuticals

Dermatologists receive variations in nature and amount of payments from pharmaceutical companies, with the top 1% receiving at least $93,622.

First Ever Drug for Duchenne Muscular Dystrophy Approved by FDA

First Ever Drug for Duchenne Muscular Dystrophy Approved by FDA

The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.

Mylan to Release Generic Version of EpiPen® In Continued Effort to Lower Costs

Mylan to Release Generic Version of EpiPen® In Continued Effort to Lower Costs

By

According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.

Mylan Takes Action To Lower Cost of EpiPens

Mylan Takes Action To Lower Cost of EpiPens

By

The pharmaceutical company has outlined steps to lower the financial burden of acquiring their products after price hike.

Free E-Newsletter